← back to search

Jinlong Yan

Nanchang University · CN
🔎 Find collaborators in Pathology and Forensic Medicine · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research focused on Cancer research and Hepatocellular carcinoma, with related work in Gene knockdown, Carcinogenesis, Perfluorooctanoic acid. Notable publications include 'Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium...', 'Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression', and 'Circular RNA DGKB Promotes the Progression of Neuroblastoma by Targeting miR-873/GLI1 Axis'.
h-index
citations
332
works
18
NIH funding
primary concept
email

Recent publications

High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression
Journal of Translational Medicine 2025cited by 10position: lastdoi
The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma
Cancer Management and Research 2024cited by 3position: middledoi
Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression
Cancer Chemotherapy and Pharmacology 2024cited by 3position: lastdoi
Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A
Molecular Cancer Therapeutics 2024cited by 2position: lastdoi
Everolimus inhibits hepatoblastoma by inducing autophagy‐dependent ferroptosis
Drug Development Research 2023cited by 8position: middledoi
<scp>MiR</scp>‐27a‐3p targets <scp>USP46</scp> to inhibit the cell proliferation of hepatocellular carcinoma
Chemical Biology & Drug Design 2022cited by 14position: lastdoi
hsa-miR-34a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury Via Targeting HNF4α
The Turkish Journal of Gastroenterology 2022cited by 11position: middledoi
DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression
Scientific Reports 2022cited by 11position: middledoi
Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib
Pediatric Surgery International 2022cited by 6position: middledoi
Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) in vitro
Environment International 2021cited by 88position: middledoi
Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1
Experimental Cell Research 2021cited by 27position: lastdoi
Clinical application of a three-dimensional reconstruction technique for complex liver cancer resection
Surgical Endoscopy 2021cited by 21position: middledoi
Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression
Infectious Agents and Cancer 2021cited by 18position: lastdoi
USP1 Promotes GC Metastasis via Stabilizing ID2
Disease Markers 2021cited by 17position: lastdoi
TLR4 Knockout Attenuates BDL-induced Liver Cholestatic Injury through Amino Acid and Choline Metabolic Pathways
Current Medical Science 2021cited by 6position: middledoi
Circular RNA DGKB Promotes the Progression of Neuroblastoma by Targeting miR-873/GLI1 Axis
Frontiers in Oncology 2020cited by 31position: middledoi
Analysis of the predictors of surgical treatment and intestinal necrosis in children with intestinal obstruction
Journal of Pediatric Surgery 2020cited by 9position: middledoi
Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression
Hepatology 2018cited by 47position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Shouhua Zhang · Nanchang University9 papers (2020–2025)Nuoya Li · Sun Yat-sen University6 papers (2021–2024)Yanling Sheng · Jiangxi University of Traditional Chinese Medicine5 papers (2021–2022)Juhua Xiao · Nanchang University3 papers (2020–2021)Bingbing Qiu · Nanchang University3 papers (2024–2025)Jiale Yang · Nanchang University3 papers (2020–2021)Leifeng Chen · Nanchang University3 papers (2018–2023)Xiangbao Yin · Nanchang University3 papers (2021–2024) · 2 papers (2020–2023)Deng Xiang · Nanchang University2 papers (2022–2024)Mengjie Yu · Nanchang University2 papers (2020–2021)Yong Chai · Nanchang University2 papers (2021–2021)Yipeng Yang · Hebei Medical University2 papers (2021–2021)Zhengyi Wu · Nanchang University2 papers (2024–2025)Jun Lei · Nanchang University2 papers (2018–2021)Shouhua Zhang · Nanchang University2 papers (2023–2024)Yumin Qiu · Sun Yat-sen University2 papers (2018–2021)Ge Jin · Hebei Medical University2 papers (2018–2021) · 2 papers (2021–2024) · 1 papers (2020–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pathology and Forensic Medicine · Oncology →